Skip to content

Avalo Therapeutics, Inc.

AVTX· NasdaqCore metricsCIK 1534120

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -9.59%
Market cap
$444.37M
57.82M shares
Filings
1,060
$59.00K
FY 2025−86.6% FY25 yoy
-$18.95M
Q3 2026N/M FY25 yoy
-$23.40M
Q3 2026N/M FY25 yoy
-$26.85M
FY 2022derivedN/M FY22 yoy
-$0.34
Q3 2026N/M FY25 yoy
$64.99M
Q3 2026−88.2% FY25 yoy
$444.37M
—
7531.7×
1.0×
—
—

FY2025 figures · derived

Price

$7.6950.10%$7.72past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$59.00KFY 2025
$27.81M0FY 2015FY 2020FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$59,000reported
FY 20242024-12-31$441,000reported
FY 20232023-12-31$1,924,000reported
FY 20222022-12-31$18,051,000reported
FY 20212021-12-31$5,398,000reported
FY 20202020-12-31$6,699,000reported
FY 20192019-12-31$6,750,351reported
FY 20182018-12-31$7,028,378 revisedreported
FY 20172017-12-31$27,813,137reported
FY 20162016-12-31$1,152,987reported
FY 20152015-12-31$0reported

Segments

Products
Revenue by Products, FY2019 to FY2025FY2019Product revenue, net · FY2019 · $6.65MLicense and other revenue · FY2019 · $100.00KFY2020Product revenue, net · FY2020 · $6.70MFY2021Product revenue, net · FY2021 · $4.77MLicense and other revenue · FY2021 · $625.00KFY2022Product revenue, net · FY2022 · $3.36MAVTX-611 · FY2022 · $200.00KLicense and other revenue · FY2022 · $14.69MFY2023Product revenue, net · FY2023 · $1.41MLicense and other revenue · FY2023 · $516.00KFY2024Product revenue, net · FY2024 · $441.00KFY2025Product revenue, net · FY2025 · $59.00K
LineFY2025ShareChange
Product revenue, net$59.00K100%−86.6%
AVTX-611———
License and other revenue———
Total$59.00K

From the 10-K filed Mar 23, 2026AVTX

Pharmaceutical preparations

Avalo Therapeutics, Inc. is the 247th largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Avalo Therapeutics, Inc. · CIK 1534120 · Engraved from SEC EDGAR